This guideline provides recommendations for the design and conduct of studies to support the efficacy of veterinary medicinal products (VMPs) intended for the reduction of the risk of transmission of vector-borne pathogens (VBPs) in dogs and cats, which can be transferred by blood-feeding arthropods. The guideline outlines the requirements for pre-clinical studies and clinical trials.
Keywords: Vector-borne disease (VBD), vector-borne pathogen (VBP), blood-feeding arthropods, reduction of the risk of transmission of VBPs, efficacy, veterinary medicinal product (VMP), ectoparasiticides, repellent effect, dog, cat